Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-077697
Filing Date
2024-03-26
Accepted
2024-03-26 17:05:36
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d763284ds3.htm S-3 507978
2 EX-1.2 d763284dex12.htm EX-1.2 187598
3 EX-4.4 d763284dex44.htm EX-4.4 296681
4 EX-4.6 d763284dex46.htm EX-4.6 96659
5 EX-4.7 d763284dex47.htm EX-4.7 94410
6 EX-4.8 d763284dex48.htm EX-4.8 85831
7 EX-5.1 d763284dex51.htm EX-5.1 32443
8 EX-23.1 d763284dex231.htm EX-23.1 1416
9 EX-FILING FEES d763284dexfilingfees.htm EX-FILING FEES 54947
10 GRAPHIC g763284g01g01.jpg GRAPHIC 46536
11 GRAPHIC g763284g0322130856750.jpg GRAPHIC 2534
  Complete submission text file 0001193125-24-077697.txt   1422182
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278246 | Film No.: 24784544
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)